Anti-Interferon-α-Therapy of systemic Lupus erythematosus

被引：0
|
作者：
Specker, C. [1 ]
机构：
[1] Kliniken Essen Sud, Zentrum Innere Med, Abt Rheumatol & Klin Immunol, D-45239 Essen, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷 / 08期
关键词：
PHASE-I; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; SAFETY;
D O I：
10.1007/s00393-013-1265-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：827 / 829
页数：3
相关论文
共 50 条
  • [1] Anti-Interferon-α-Therapie des systemischen Lupus erythematodesAnti-interferon alpha therapy of systemic lupus erythematosus
    C. Specker
    [J]. Zeitschrift für Rheumatologie, 2013, 72 (8) : 827 - 829
  • [2] Population Pharmacokinetics of Sifalimumab, an Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus
    Narwal, Rajesh
    Roskos, Lorin K.
    Robbie, Gabriel J.
    [J]. CLINICAL PHARMACOKINETICS, 2013, 52 (11) : 1017 - 1027
  • [3] Population Pharmacokinetics of Sifalimumab, an Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus
    Rajesh Narwal
    Lorin K. Roskos
    Gabriel J. Robbie
    [J]. Clinical Pharmacokinetics, 2013, 52 : 1017 - 1027
  • [4] Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
    Furie, Richard
    Khamashta, Munther
    Merrill, Joan T.
    Werth, Victoria P.
    Kalunian, Kenneth
    Brohawn, Philip
    Illei, Gabor G.
    Drappa, Jorn
    Wang, Liangwei
    Yoo, Stephen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 376 - 386
  • [5] Population Pharmacokinetics of Sifalimumab, An Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus Patients
    Narwal, Rajesh
    Roskos, Lorin
    White, Wendy
    Greth, Warren
    Robbie, Gabriel
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S546 - S546
  • [6] Association of Endogenous Anti-Interferon-α Autoantibodies With Decreased Interferon-Pathway and Disease Activity in Patients With Systemic Lupus Erythematosus
    Morimoto, Alyssa M.
    Flesher, Donna Thibault
    Yang, Jihong
    Wolslegel, Kristen
    Wang, Xiangdan
    Brady, Ann
    Abbas, Alexander R.
    Quarmby, Valerie
    Wakshull, Eric
    Richardson, Bruce
    Townsend, Michael J.
    Behrens, Timothy W.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2407 - 2415
  • [7] Anifrolumab Anti-interferon-α receptor 1(IFNAR1) monoclonal antibody Treatment of systemic lupus erythematosus
    Haddley, K.
    [J]. DRUGS OF THE FUTURE, 2018, 43 (07) : 471 - 481
  • [8] Neutralization of Interferon-α/β-Inducible Genes and Downstream Effect in a Phase I Trial of an Anti-Interferon-α Monoclonal Antibody in Systemic Lupus Erythematosus
    Yao, Yihong
    Richman, Laura
    Higgs, Brandon W.
    Morehouse, Christopher A.
    de los Reyes, Melissa
    Brohawn, Philip
    Zhang, Jianliang
    White, Barbara
    Coyle, Anthony J.
    Kiener, Peter A.
    Jallal, Bahija
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (06): : 1785 - 1796
  • [9] Systemic lupus erythematosus syndrome induced by interferon therapy
    Alfaro, EM
    Rodríguez, FM
    Sancho, JJB
    Rodríguez, IT
    [J]. MEDICINA CLINICA, 2004, 123 (15): : 597 - 597
  • [10] SYSTEMIC LUPUS-ERYTHEMATOSUS FOLLOWING INTERFERON THERAPY
    FLORES, A
    OLIVE, A
    FELIU, E
    TENA, X
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (08): : 787 - 787
12345